Psychiatry Search
Psychiatry Psychiatry
depression
DEPRESSION

Depression is a mood disorder wherein the patient have a pervasive sad mood or loss of interest in most activities for at least 2 weeks.

It can cause significant distress & impairment. It is also a chronic, episodic and relapsing syndrome.

Treatment can either be by psychotherapy alone or pharmacotherapy alone or psychotherapy combined with pharmacological therapy.

Introduction

  • Patients may not present with depressive mood; somatic complaints may predominate
  • Depression should be suspected in patients who present with physical symptoms (eg fatigue, gastrointestinal distress or back pain) which cannot be explained or in those who present with pain, anxiety or substance abuse
  • Presence of depressed mood or diminished interest or pleasure in activities (anhedonia), feeling of fatigue or lack of energy (anergia), significant loss of motivation (avolition) are essential in diagnosing depression
  • Diagnosis may be easier in patients who are more aware of their moods or functioning
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Sertraline may prevent depressive disorders after traumatic brain injury
19 Sep 2016
Sertraline may prevent the onset of depressive disorders after traumatic brain injury (TBI), a randomized trial showed.
Healthy eating wards off depression
23 Jul 2019
Eating healthy foods, especially those following the Mediterranean dietary pattern, or avoiding proinflammatory diet appears to exert a protective effect on the risk of depression, according to a systematic review and meta-analysis.
Hormonal contraceptive users are at risk of depression
09 Oct 2016
The use of hormonal contraception increases the risk of subsequent use of antidepressants and a first diagnosis of depression, results of a study show.
Vortioxetine lessens depressive and anxiety symptoms in MDD patients with high anxiety
01 Dec 2016
Vortioxetine 5-20 mg/day lessens depression and anxiety severity in patients with major depressive disorder (MDD) and high levels of anxiety, as observed in a meta-analysis of 10 randomised, placebo-controlled, 6/8-week trials.